The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Projected To Reach By 2030?
The asthma and chronic obstructive pulmonary disease (copd) drugs market has demonstrated significant expansion over recent years. Forecasts show that its size is set to climb from $35.66 billion in 2025 to $39.07 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. This historical increase can be linked to factors like rising smoking prevalence, urban air pollution, hospital-based respiratory care, the adoption of inhaler technology, and an increase in asthma diagnosis.
The market for asthma and chronic obstructive pulmonary disease (COPD) drugs is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $55.67 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. Key drivers contributing to this growth during the forecast period include advancements in biologic drugs, an increasingly elderly global population, declining air quality, the emergence of personalized respiratory medicine, and the availability of homecare respiratory solutions. Notable trends anticipated in this period encompass the heightened utilization of combination inhaler therapies, a wider uptake of long-acting bronchodilators, the broadening application of biologic treatments for severe asthma, a transition towards managing respiratory conditions at home, and an increasing appetite for generic inhalation medications.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24472&type=smp
Which Key Drivers Are Affecting The Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Development?
The rising incidence of smoking is anticipated to drive expansion in the asthma and COPD drugs market moving forward. Smoking describes the practice of consuming tobacco items through smoke inhalation, potentially resulting in severe health problems like lung cancer and heart disease. Social influence largely fuels the growing prevalence of smoking, with factors such as peer pressure, societal norms, and social surroundings motivating individuals to initiate and maintain smoking habits. Medications for asthma and chronic obstructive pulmonary disease (COPD) aid in counteracting the respiratory harm inflicted by smoking by lessening inflammation, relaxing airway muscles, and improving air circulation, thus easing symptoms and boosting lung performance. For example, in 2024, a study conducted by the European Respiratory Society’s (ERS), a Switzerland-based non-profit organization, on youth smoking trends revealed a significant surge in smoking rates, climbing from 22.5% of survey participants in 2022 to 40.1% in 2024. Consequently, the expanding prevalence of smoking is propelling the growth of the asthma and COPD drugs market.
How Is The Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Segmented Across Different Segment Categories?
The asthma and chronic obstructive pulmonary disease (copd) drugs market covered in this report is segmented –
1) By Drug Class: Bronchodilators, Corticosteroids, Combination Drugs, Leukotriene Modifiers
2) By Route Of Administration: Inhalation, Oral, Injection, Other Route Of Administrations
3) By Patient Group: Adult, Pediatric, Geriatric
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
Subsegments:
1) By Bronchodilators: Short-Acting Beta-2 Agonists (SABA), Long-Acting Beta-2 Agonists (LABA), Anticholinergics, Long-Acting Muscarinic Antagonists, Methylxanthines
2) By Corticosteroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Intravenous Corticosteroids
3) By Combination Drugs: Long-Acting Beta-Agonist + Inhaled Corticosteroid, Long-Acting Beta-Agonist + Long-Acting Muscarinic Antagonist, Long-Acting Beta-Agonist + Long-Acting Muscarinic Antagonist + Inhaled Corticosteroid
4) By Leukotriene Modifiers: Leukotriene Receptor Antagonists, Leukotriene Synthesis Inhibitors
What Trends Are Transforming The Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market?
Major companies within the asthma and chronic obstructive pulmonary disease (COPD) drugs market are increasingly focusing on integrating innovative drug-combination therapies, such as short-acting beta-agonist (SABA) and inhaled corticosteroid (ICS) rescue inhalers. This focus aims to provide enhanced benefits, including the prevention of severe asthma attacks, improved inflammation control, and better overall disease management. A SABA–ICS rescue inhaler combines a short-acting beta-agonist, which rapidly relaxes airway muscles to alleviate symptoms, with an inhaled corticosteroid that reduces underlying airway inflammation. This dual action provides immediate symptom relief alongside anti-inflammatory effects. For instance, in January 2024, AstraZeneca, a UK-based biopharmaceutical company, launched AIRSUPRA (albuterol/budesonide) in the US. This fixed-dose SABA-ICS rescue inhaler is designed to treat asthma symptoms and help prevent sudden severe breathing problems, featuring its dual-component formulation delivered via pressurised metered-dose inhaler (pMDI) Aerosphere technology. AIRSUPRA improves acute symptom relief while simultaneously addressing airway inflammation, thereby reducing the risk of severe asthma exacerbations and enhancing overall asthma control.
Which Organizations Play A Role In The Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Landscape?
Major companies operating in the asthma and chronic obstructive pulmonary disease (copd) drugs market are Sun Pharmaceutical Industries Ltd., Viatris Inc., Hikma Pharmaceuticals PLC, Orion Corporation, Bausch Health Companies Inc., Kyorin Pharmaceutical Co. Ltd., Sandoz International GmbH, Mundipharma International Ltd., Ferrer Internacional S.A., Neopharm Group, Covis Pharma Group, Almirall S.A., Menarini Group, Cipla Health Ltd., Indoco Remedies Ltd., Intas Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Wockhardt Ltd., Ajanta Pharma Ltd., Emcure Pharmaceuticals Ltd., Abbott Laboratories, Endo International plc, Takeda Pharmaceutical Company Ltd.
Get The Full Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Report:
Which Region Holds The Highest Market Share In The Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market?
North America was the largest region in the asthma and COPD drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma and chronic obstructive pulmonary disease (copd) drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Asthma And Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2026, By The Business Research Company
Anti Asthmatics And Copd Drugs Market Report 2026
Digital Dose Inhalers Market Report 2026
https://www.thebusinessresearchcompany.com/report/digital-dose-inhalers-global-market-report
Inhaled Antibiotics Market Report 2026
https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model